High Dose Ace Inhibitor Therapy Versus Combination of ACE and ARB Therapy
Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
Investigation of wheather addition of angiotensin receptor blocker (Irbesartan) to
recommended doses of angiotensin converting enzyme inhibitor (trandolapril) is more effective
in decreasing amount of protein in urine in patients with diabetic kidney disease than high
doses of trandolapril.